Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CorMedix (CRMD) Current Assets (2016 - 2025)

Historic Current Assets for CorMedix (CRMD) over the last 13 years, with Q3 2025 value amounting to $259.5 million.

  • CorMedix's Current Assets rose 25477.8% to $259.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $259.5 million, marking a year-over-year increase of 25477.8%. This contributed to the annual value of $114.6 million for FY2024, which is N/A changed from last year.
  • According to the latest figures from Q3 2025, CorMedix's Current Assets is $259.5 million, which was up 25477.8% from $248.1 million recorded in Q2 2025.
  • CorMedix's Current Assets' 5-year high stood at $259.5 million during Q3 2025, with a 5-year trough of $53.2 million in Q2 2024.
  • In the last 5 years, CorMedix's Current Assets had a median value of $69.7 million in 2021 and averaged $94.8 million.
  • As far as peak fluctuations go, CorMedix's Current Assets crashed by 2474.7% in 2022, and later soared by 36632.16% in 2025.
  • Over the past 5 years, CorMedix's Current Assets (Quarter) stood at $66.5 million in 2021, then dropped by 10.41% to $59.6 million in 2022, then skyrocketed by 49.56% to $89.1 million in 2023, then increased by 28.65% to $114.6 million in 2024, then soared by 126.52% to $259.5 million in 2025.
  • Its last three reported values are $259.5 million in Q3 2025, $248.1 million for Q2 2025, and $144.9 million during Q1 2025.